The US Diabetic Devices Industry Outlook to 2018 - Growth to be Led by Next Generation Technology
The report titled “The US Diabetic Devices Industry Outlook to 2018- Growth to be Led by Next Generation Technology” presents a comprehensive analysis of the industry covering aspects including market size of SMBG devices, CGM systems and Insulin Delivery Devices market by revenue and market segmentation by product categories in SMBG devices and Insulin Delivery Devices market. The report also entails a detailed description on the recent trends and developments in the diabetic care devices market and competitive scenario of major players in the industry along with market share of major companies in SMBG devices and Insulin Delivery devices market.
The Diabetic Care Devices Market in the US has transformed from niche to mainstream, owing to the increasing number of diabetic patients and growing ageing population in the country. Diabetic equipments have slowly become an integral part of present day’s fast paced lifestyles along with other changes such as increasing acceptability and affordability of these products. New product launches in this market has been driven by escalating demand of diabetic care devices by the diabetic population of the country. The US diabetic devices industry grew from USD ~ million in 2007 to USD ~ million in 2013, recording a CAGR of 7.7% from 2007-2013.This market is dominated by players such as Roche Diagnostics, Life Scan and Abbott Diabetes Care.
The US Diabetic Care devices market has been predominantly held by SMBG devices, marking a contribution of nearly ~ % as recorded in 2013. The market share of this segment has decreased significantly from ~% in 2010 to ~% in 2013 but the segment continues to hold the largest share in the diabetic care devices market revenue in the country. The insulin delivery devices accounted for approximately ~ % of the diabetic care devices revenue in the country in the year 2013. CGM devices were introduced in the market in 1999. The US is a leading player in the CGM market in terms of revenue generation. This market segment made a petite contribution of ~% to the total revenue of diabetic care devices industry in the year 2013.
The use of SMBG has been advocated for several years as an approach to improve blood glucose control for people suffering from Type I and Type II diabetes. Blood glucose meters, blood glucose test strips and lancets and lancing devices constitute the SMBG devices market. The market was valued at USD ~ million in 2007; having grown to USD ~ million in 2013 at a CAGR of ~% during the period of 2007-2013. The market is expected to reach USD ~ million by 2018. Roche Diagnostics and LifeScan occupied the largest share in the SMBG market in 2013. The SMBG devices market will benefit from the appearance and growing attractiveness of CGM.
CGM System offers regular glucose measurements, usually every few minutes. This is a highly useful device as it provides greater insight into blood glucose levels all day by instilling a small sensor under the skin. In the forthcoming years, it is expected that such implantable sensors might robotically adjust for infusion rates provided by the insulin pump. The industry reached USD ~ million in 2013 from USD ~ million in 2010, showing a phenomenal growth, recording an impressive CAGR of ~% during the period 2010-2013. Medtronic and Dexcom are leading players in the industry. Artificial Pancreas, a combination of CGM Device and Insulin Delivery Device, cannot be defined as a cure for diabetes but certainly helps in enhanced control and management of the disease by trimming down the burden of monitoring and managing blood glucose.
The insulin delivery market occupied ~% market share which makes it the second largest segment of the US Diabetic devices market in the year 2013. The market reported value sales of USD ~ million in 2013. The market for diabetic care has been dominated by insulin pens. The share of insulin syringe has declined over the years due to the launch of potential diabetic device substitutes such as insulin pens and artificial pancreas. The insulin pump market generated USD ~ million in 2013. Its contribution in insulin delivery market segment has surged from ~% in 2007 to ~ % in 2013. Medtronic, Novo Nordisk and Sanofi are leading players in the insulin delivery devices market. The market is expected to grow at a CAGR of ~% in the coming years, 2013-2018 with the market size reaching USD ~ million in 2018 from USD ~ million in 2014.
KEY TOPICS COVERED IN THE REPORT
The Diabetic Care Devices Market in the US has transformed from niche to mainstream, owing to the increasing number of diabetic patients and growing ageing population in the country. Diabetic equipments have slowly become an integral part of present day’s fast paced lifestyles along with other changes such as increasing acceptability and affordability of these products. New product launches in this market has been driven by escalating demand of diabetic care devices by the diabetic population of the country. The US diabetic devices industry grew from USD ~ million in 2007 to USD ~ million in 2013, recording a CAGR of 7.7% from 2007-2013.This market is dominated by players such as Roche Diagnostics, Life Scan and Abbott Diabetes Care.
The US Diabetic Care devices market has been predominantly held by SMBG devices, marking a contribution of nearly ~ % as recorded in 2013. The market share of this segment has decreased significantly from ~% in 2010 to ~% in 2013 but the segment continues to hold the largest share in the diabetic care devices market revenue in the country. The insulin delivery devices accounted for approximately ~ % of the diabetic care devices revenue in the country in the year 2013. CGM devices were introduced in the market in 1999. The US is a leading player in the CGM market in terms of revenue generation. This market segment made a petite contribution of ~% to the total revenue of diabetic care devices industry in the year 2013.
The use of SMBG has been advocated for several years as an approach to improve blood glucose control for people suffering from Type I and Type II diabetes. Blood glucose meters, blood glucose test strips and lancets and lancing devices constitute the SMBG devices market. The market was valued at USD ~ million in 2007; having grown to USD ~ million in 2013 at a CAGR of ~% during the period of 2007-2013. The market is expected to reach USD ~ million by 2018. Roche Diagnostics and LifeScan occupied the largest share in the SMBG market in 2013. The SMBG devices market will benefit from the appearance and growing attractiveness of CGM.
CGM System offers regular glucose measurements, usually every few minutes. This is a highly useful device as it provides greater insight into blood glucose levels all day by instilling a small sensor under the skin. In the forthcoming years, it is expected that such implantable sensors might robotically adjust for infusion rates provided by the insulin pump. The industry reached USD ~ million in 2013 from USD ~ million in 2010, showing a phenomenal growth, recording an impressive CAGR of ~% during the period 2010-2013. Medtronic and Dexcom are leading players in the industry. Artificial Pancreas, a combination of CGM Device and Insulin Delivery Device, cannot be defined as a cure for diabetes but certainly helps in enhanced control and management of the disease by trimming down the burden of monitoring and managing blood glucose.
The insulin delivery market occupied ~% market share which makes it the second largest segment of the US Diabetic devices market in the year 2013. The market reported value sales of USD ~ million in 2013. The market for diabetic care has been dominated by insulin pens. The share of insulin syringe has declined over the years due to the launch of potential diabetic device substitutes such as insulin pens and artificial pancreas. The insulin pump market generated USD ~ million in 2013. Its contribution in insulin delivery market segment has surged from ~% in 2007 to ~ % in 2013. Medtronic, Novo Nordisk and Sanofi are leading players in the insulin delivery devices market. The market is expected to grow at a CAGR of ~% in the coming years, 2013-2018 with the market size reaching USD ~ million in 2018 from USD ~ million in 2014.
KEY TOPICS COVERED IN THE REPORT
- Market Size of the US Diabetic Care Devices Market Size by Revenue, 2007-2013
- Market Segmentation of the US Diabetic Devices by SMBG Devices, CGM Systems and Insulin Delivery Devices, 2010-2013
- Market Segmentation of SMBG Devices by Blood Glucose Meters, Blood Glucose Test Strips and Lancets and Lancing Devices, 2007-2013
- Market Segmentation of Insulin Delivery Devices by Insulin Syringe, Insulin Pen and Insulin Pump, 2007-2013
- Market Size of the US CGM Devices Market by Revenue, 2010-2013
- Market share of Major players in the US CGM Devices Market
- Market Share of Major Players in sub segments of SMBG Devices Market and Insulin Delivery Devices.
- Trends and Developments in the US Diabetic Care Devices Market
- Future Outlook and Projections of SMBG Devices, CGM Systems and Insulin Delivery Devices, 2014-2018
1. THE US DIABETES CARE DEVICES MARKET INTRODUCTION
1.1. What is Diabetes and it’s Types?
2. THE US DIABETES CARE DEVICES MARKET SIZE, 2007-2013
3. THE US DIABETES CARE DEVICES MARKET SEGMENTATION, 2007-2013
3.1. By Blood Sugar Monitoring Devices, CGM Devices and Insulin Delivery Devices, 2010-2013
3.2. The US Self Blood Glucose Monitoring Devices Market Introduction
3.2.1. The US Self Blood Glucose Monitoring Devices Market Size, 2007-2013
3.2.2. The US Self Blood Glucose Monitoring Devices Market Segmentation by Blood Glucose Meters, Blood Glucose Test Strips and Lancets and Lancing Devices, 2007-2013
3.2.2.1. The US Blood Glucose Meters Market Size, 2007-2013
3.2.2.2. Market Share of Major Players in the US Blood Glucose Meters Market, 2012
3.2.2.3. The US Blood Glucose Test Strips Market Size, 2007-2013
3.2.2.4. Market Share of Major Players in the US Blood Glucose Test Strips Market, 2012
3.2.2.5. The US Lancets and Lancing Devices Market Size, 2007-2013
3.2.2.6. Market Share of Major Players in the US Lancets and Lancing Devices Market, 2012
3.2.3. The US SMBG Devices Market Future Outlook and Projections, 2014 -2018
3.3. The US CGM Systems Market Introduction
3.3.1. The US CGM Systems Market Size, 2010-2013
3.3.2. Market Share of Major Players in the US CGM Systems Market, 2012
3.3.3. The US CGM Systems Market Future Outlook and Projections of, 2014-2018
3.4. The US Insulin Delivery Devices Market Size and Introduction, 2007-2013
3.4.1. The US Insulin Delivery Devices Market Segmentation by Insulin Pens, Insulin Syringes, Insulin Pumps, 2007-2013
3.4.1.1. The US Insulin Pens Market Size, 2007-2013
3.4.1.2. Market Share of Major Players in the US Insulin Pens Market, 2012
3.4.1.3. The US Insulin Pumps Market Size, 2007-2013
3.4.1.4. Market Share of Major Players in the US Insulin Pumps Market, 2012
3.4.1.5. The US Insulin Syringe Market Size, 2007-2013
3.4.1.6. Market Share of Major Players in the US Insulin Syringe Market, 2012
3.4.2. The US Insulin Delivery Devices Market Future Outlook and Projections, 2014-2018
3.5. Cause & Effect Relationship Analysis in the US Diabetic Care Devices Industry
4. ARTIFICIAL PANCREAS - THE ULTIMATE GOAL
5. TRENDS AND DEVELOPMENTS IN THE US DIABETIC CARE DEVICES MARKET
6. PREVALENCE OF DIABETES ACROSS THE US STATES
7. PATENTS SCENARIO IN THE US DIABETIC THERAPEUTIC MARKET
8. STRATEGIC PARTNERSHIPS AND ACQUISITIONS IN THE US DIABETIC MARKET
9. THE US DIABETIC CARE DEVICES MARKET SWOT ANALYSIS
10. COMPANY PROFILES OF MAJOR PLAYERS IN THE US DIABETIC CARE DEVICES MARKET
11. THE US DIABETIC CARE DEVICES MARKET FUTURE OUTLOOK AND PROJECTIONS, 2014-2018
12. THE US MACRO ECONOMIC INDICATORS: CURRENT AND PROJECTIONS
12.1. Ageing Population in the US, 2007-2018
12.2. Consumer Healthcare Expenditure, 2007-2018
12.3. Diabetic Population in the US, 2007-2018
13. APPENDIX
13.1. Market Definitions
13.2. Abbreviations
13.3. Research Methodology
Data Collection Methods
Approach
Variables (Dependent and Independent)
Multi Factor Based Sensitivity Model
Final Conclusion
13.4. Disclaimer
1.1. What is Diabetes and it’s Types?
2. THE US DIABETES CARE DEVICES MARKET SIZE, 2007-2013
3. THE US DIABETES CARE DEVICES MARKET SEGMENTATION, 2007-2013
3.1. By Blood Sugar Monitoring Devices, CGM Devices and Insulin Delivery Devices, 2010-2013
3.2. The US Self Blood Glucose Monitoring Devices Market Introduction
3.2.1. The US Self Blood Glucose Monitoring Devices Market Size, 2007-2013
3.2.2. The US Self Blood Glucose Monitoring Devices Market Segmentation by Blood Glucose Meters, Blood Glucose Test Strips and Lancets and Lancing Devices, 2007-2013
3.2.2.1. The US Blood Glucose Meters Market Size, 2007-2013
3.2.2.2. Market Share of Major Players in the US Blood Glucose Meters Market, 2012
3.2.2.3. The US Blood Glucose Test Strips Market Size, 2007-2013
3.2.2.4. Market Share of Major Players in the US Blood Glucose Test Strips Market, 2012
3.2.2.5. The US Lancets and Lancing Devices Market Size, 2007-2013
3.2.2.6. Market Share of Major Players in the US Lancets and Lancing Devices Market, 2012
3.2.3. The US SMBG Devices Market Future Outlook and Projections, 2014 -2018
3.3. The US CGM Systems Market Introduction
3.3.1. The US CGM Systems Market Size, 2010-2013
3.3.2. Market Share of Major Players in the US CGM Systems Market, 2012
3.3.3. The US CGM Systems Market Future Outlook and Projections of, 2014-2018
3.4. The US Insulin Delivery Devices Market Size and Introduction, 2007-2013
3.4.1. The US Insulin Delivery Devices Market Segmentation by Insulin Pens, Insulin Syringes, Insulin Pumps, 2007-2013
3.4.1.1. The US Insulin Pens Market Size, 2007-2013
3.4.1.2. Market Share of Major Players in the US Insulin Pens Market, 2012
3.4.1.3. The US Insulin Pumps Market Size, 2007-2013
3.4.1.4. Market Share of Major Players in the US Insulin Pumps Market, 2012
3.4.1.5. The US Insulin Syringe Market Size, 2007-2013
3.4.1.6. Market Share of Major Players in the US Insulin Syringe Market, 2012
3.4.2. The US Insulin Delivery Devices Market Future Outlook and Projections, 2014-2018
3.5. Cause & Effect Relationship Analysis in the US Diabetic Care Devices Industry
4. ARTIFICIAL PANCREAS - THE ULTIMATE GOAL
5. TRENDS AND DEVELOPMENTS IN THE US DIABETIC CARE DEVICES MARKET
6. PREVALENCE OF DIABETES ACROSS THE US STATES
7. PATENTS SCENARIO IN THE US DIABETIC THERAPEUTIC MARKET
8. STRATEGIC PARTNERSHIPS AND ACQUISITIONS IN THE US DIABETIC MARKET
9. THE US DIABETIC CARE DEVICES MARKET SWOT ANALYSIS
10. COMPANY PROFILES OF MAJOR PLAYERS IN THE US DIABETIC CARE DEVICES MARKET
11. THE US DIABETIC CARE DEVICES MARKET FUTURE OUTLOOK AND PROJECTIONS, 2014-2018
12. THE US MACRO ECONOMIC INDICATORS: CURRENT AND PROJECTIONS
12.1. Ageing Population in the US, 2007-2018
12.2. Consumer Healthcare Expenditure, 2007-2018
12.3. Diabetic Population in the US, 2007-2018
13. APPENDIX
13.1. Market Definitions
13.2. Abbreviations
13.3. Research Methodology
Data Collection Methods
Approach
Variables (Dependent and Independent)
Multi Factor Based Sensitivity Model
Final Conclusion
13.4. Disclaimer
LIST OF FIGURES
Figure 1: The US Diabetic Care Devices Market Size by Revenue in USD Million, 2007-2013
Figure 2: The US Diabetic Care Devices Segmentation by SMBG devices, CGM devices and Insulin Delivery Systems on the Basis of Revenue in Percentage (%), 2010- 2013
Figure 3: The US Self Monitoring Blood Glucose Devices Market Size by Revenue in USD Million, 2007-2013
Figure 4: The US SMBG Devices Segmentation by Glucose Meters, Blood Glucose Test Strips and Lancets and Lancing Devices on the Basis of Revenue in Percentage (%), 2007-2013
Figure 5: The US Blood Glucose Meters Market Size by Revenue in USD Million, 2007-2013
Figure 6: Market Share of Major Players in the US Blood Glucose Meters Market on the Basis of Revenue in Percentage (%), 2012
Figure 7: The US Blood Glucose Test Strips Market Size by Revenue in USD Million, 2007-2013
Figure 8: Market Share of Major Players in the US Blood Glucose Test Strips Market on the Basis of Revenue in Percentage (%), 2012
Figure 9: The US Lancets and Lancing Devices Market Size by Revenue in USD Million, 2007-2013
Figure 10: Market Share of Major Players in the US Lancets and Lancing Devices Market on the Basis of Revenue in Percentage (%), 2012
Figure 11: The US SMBG Market Future Projections on the Basis of Revenue in USD Million, 2014 -2018
Figure 12: The US Continuous Glucose Monitoring Systems Market Size by Revenue in USD Million, 2007-2013
Figure 13: Market Share of Major Players in the US CGM systems Market on the Basis of Revenue in Percentage (%), 2012
Figure 14: The US CGM Systems Future Projections on the Basis of Revenue in USD Million, 2014-2018
Figure 15: The US Insulin Delivery Devices Market Size by Revenue in USD Million, 2007-2013
Figure 16: The US Insulin Delivery Devices Segmentation by Insulin Pen, Insulin Syringe and Insulin Pump on the Basis of Revenue in Percentage (%), 2007-2013
Figure 17: The US Insulin Pens Market Size by Revenue in USD Million, 2007- 2013
Figure 18: Market Share of Major Players in the US Insulin Pens Market on the Basis of Revenue in Percentage (%), 2012
Figure 19: The US Insulin Pumps Market Size by Revenue in USD Million, 2007-2013
Figure 20: Market Share of Major Players in the US Insulin Pumps Market on the Basis of Revenue in Percentage (%), 2012
Figure 21: The US Insulin Syringe Market Size by Revenue in USD Million, 2007-2013
Figure 22: Market Share of Major Players in the US Insulin Syringe Market on the Basis of Revenue in Percentage (%), 2012
Figure 23: The US Insulin Delivery Devices Market Future Projections on the Basis of Revenue in USD Million, 2014-2018
Figure 24: The US Diabetic Care Devices Market Future Projections by Insulin Delivery Systems, CGM devices and SMBG Device on the Basis of Revenue in Percentage (%), 2014-2018
Figure 25: The US Ageing Population in Million and the Proportion of Population above 65 Years as a Percentage (%) of Total Population, 2007-2018
Figure 26: The US Healthcare Expenditure in USD Billion, 2007-2018
Figure 27: Diabetes Patients in the US in Million, 2007-2018
Figure 1: The US Diabetic Care Devices Market Size by Revenue in USD Million, 2007-2013
Figure 2: The US Diabetic Care Devices Segmentation by SMBG devices, CGM devices and Insulin Delivery Systems on the Basis of Revenue in Percentage (%), 2010- 2013
Figure 3: The US Self Monitoring Blood Glucose Devices Market Size by Revenue in USD Million, 2007-2013
Figure 4: The US SMBG Devices Segmentation by Glucose Meters, Blood Glucose Test Strips and Lancets and Lancing Devices on the Basis of Revenue in Percentage (%), 2007-2013
Figure 5: The US Blood Glucose Meters Market Size by Revenue in USD Million, 2007-2013
Figure 6: Market Share of Major Players in the US Blood Glucose Meters Market on the Basis of Revenue in Percentage (%), 2012
Figure 7: The US Blood Glucose Test Strips Market Size by Revenue in USD Million, 2007-2013
Figure 8: Market Share of Major Players in the US Blood Glucose Test Strips Market on the Basis of Revenue in Percentage (%), 2012
Figure 9: The US Lancets and Lancing Devices Market Size by Revenue in USD Million, 2007-2013
Figure 10: Market Share of Major Players in the US Lancets and Lancing Devices Market on the Basis of Revenue in Percentage (%), 2012
Figure 11: The US SMBG Market Future Projections on the Basis of Revenue in USD Million, 2014 -2018
Figure 12: The US Continuous Glucose Monitoring Systems Market Size by Revenue in USD Million, 2007-2013
Figure 13: Market Share of Major Players in the US CGM systems Market on the Basis of Revenue in Percentage (%), 2012
Figure 14: The US CGM Systems Future Projections on the Basis of Revenue in USD Million, 2014-2018
Figure 15: The US Insulin Delivery Devices Market Size by Revenue in USD Million, 2007-2013
Figure 16: The US Insulin Delivery Devices Segmentation by Insulin Pen, Insulin Syringe and Insulin Pump on the Basis of Revenue in Percentage (%), 2007-2013
Figure 17: The US Insulin Pens Market Size by Revenue in USD Million, 2007- 2013
Figure 18: Market Share of Major Players in the US Insulin Pens Market on the Basis of Revenue in Percentage (%), 2012
Figure 19: The US Insulin Pumps Market Size by Revenue in USD Million, 2007-2013
Figure 20: Market Share of Major Players in the US Insulin Pumps Market on the Basis of Revenue in Percentage (%), 2012
Figure 21: The US Insulin Syringe Market Size by Revenue in USD Million, 2007-2013
Figure 22: Market Share of Major Players in the US Insulin Syringe Market on the Basis of Revenue in Percentage (%), 2012
Figure 23: The US Insulin Delivery Devices Market Future Projections on the Basis of Revenue in USD Million, 2014-2018
Figure 24: The US Diabetic Care Devices Market Future Projections by Insulin Delivery Systems, CGM devices and SMBG Device on the Basis of Revenue in Percentage (%), 2014-2018
Figure 25: The US Ageing Population in Million and the Proportion of Population above 65 Years as a Percentage (%) of Total Population, 2007-2018
Figure 26: The US Healthcare Expenditure in USD Billion, 2007-2018
Figure 27: Diabetes Patients in the US in Million, 2007-2018
LIST OF TABLES
Table 1: Standard Blood Glucose Levels in the Human Body
Table2: The US Diabetic Care Devices Market Segmentation by SMBG devices, CGM devices and Insulin Delivery Systems on the Basis of Revenue in USD Million, 2010 -2013
Table 3: The US SMBG Devices Market Segmentation by Glucose Meters, Blood Glucose Test Strips and Lancets and Lancing Devices on the Basis of Revenue in USD Million, 2007-2013
Table 4: The US Insulin Delivery Devices Market Segmentation by Insulin Pen, Insulin Syringe and Insulin Pump on the Basis of Revenue in USD Million, 2007-2013
Table 5: Advantages and Disadvantages of Different Types of Insulin Delivery Devices
Table 6: Cause and Effect Relationship between the Dependent and Independent Variables Prevailing in the US Diabetic Care Devices Market
Table 7: Alternate modes of Insulin Delivery
Table 8: Top Ten States with the Highest Obesity Rates in the US
Table 9: Top Ten States with the Highest Rates of High Blood Pressure in the US
Table 10: Top Ten States with the Highest Diabetes Rate in the US
Table 11: Diabetic Patents in the US by Patent Number, Inventors, Filing Date and Publication Date
Table 12: Acquisitions in the US Diabetic Market, 2011-2012
Table 13: Strategic Partnerships in the US Diabetic Market, 2008-2012
Table 14: Competitive Landscape of Major Players (Medtronics, Dexcom inc, Abbot laboratories, Roche Diagnostics, Insulet Corporation, LifeScan Inc, Novo Nordisk) in the US Diabetic Care Devices Market
Table 15: The US Diabetic Care Devices Market Future Projections by Insulin Delivery Systems, CGM devices and SMBG Device on the Basis of Revenue in USD Million, 2014-2018
Table 16: Healthcare Expenditure Pattern of US Adults by Contribution in Percentage (%), 2012
Table 17: Type I and Type II Diabetes Population in the US in Million, 2007-2013
Table 18: Correlation Matrix of the US CGM Devices Market
Table 19: Regression Coefficients Output of the US CGM Devices Market
Table 1: Standard Blood Glucose Levels in the Human Body
Table2: The US Diabetic Care Devices Market Segmentation by SMBG devices, CGM devices and Insulin Delivery Systems on the Basis of Revenue in USD Million, 2010 -2013
Table 3: The US SMBG Devices Market Segmentation by Glucose Meters, Blood Glucose Test Strips and Lancets and Lancing Devices on the Basis of Revenue in USD Million, 2007-2013
Table 4: The US Insulin Delivery Devices Market Segmentation by Insulin Pen, Insulin Syringe and Insulin Pump on the Basis of Revenue in USD Million, 2007-2013
Table 5: Advantages and Disadvantages of Different Types of Insulin Delivery Devices
Table 6: Cause and Effect Relationship between the Dependent and Independent Variables Prevailing in the US Diabetic Care Devices Market
Table 7: Alternate modes of Insulin Delivery
Table 8: Top Ten States with the Highest Obesity Rates in the US
Table 9: Top Ten States with the Highest Rates of High Blood Pressure in the US
Table 10: Top Ten States with the Highest Diabetes Rate in the US
Table 11: Diabetic Patents in the US by Patent Number, Inventors, Filing Date and Publication Date
Table 12: Acquisitions in the US Diabetic Market, 2011-2012
Table 13: Strategic Partnerships in the US Diabetic Market, 2008-2012
Table 14: Competitive Landscape of Major Players (Medtronics, Dexcom inc, Abbot laboratories, Roche Diagnostics, Insulet Corporation, LifeScan Inc, Novo Nordisk) in the US Diabetic Care Devices Market
Table 15: The US Diabetic Care Devices Market Future Projections by Insulin Delivery Systems, CGM devices and SMBG Device on the Basis of Revenue in USD Million, 2014-2018
Table 16: Healthcare Expenditure Pattern of US Adults by Contribution in Percentage (%), 2012
Table 17: Type I and Type II Diabetes Population in the US in Million, 2007-2013
Table 18: Correlation Matrix of the US CGM Devices Market
Table 19: Regression Coefficients Output of the US CGM Devices Market
